JPMorgan raised the firm’s price target on Visteon to $160 from $157 and keeps a Neutral rating on the shares. The company reported mixed Q3 results featuring softer revenue but stronger margin allowing for higher EBITDA dollars while also becoming one of a minority of suppliers this quarter to have raised full year outlook, the analyst tells investors in a research note. The firm cites slightly higher estimates for the target dump.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VC: